0000898432-23-000272.txt : 20230508
0000898432-23-000272.hdr.sgml : 20230508
20230508184006
ACCESSION NUMBER: 0000898432-23-000272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230505
FILED AS OF DATE: 20230508
DATE AS OF CHANGE: 20230508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Susi Roger E.
CENTRAL INDEX KEY: 0001613801
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36534
FILM NUMBER: 23899415
MAIL ADDRESS:
STREET 1: C/O IRADIMED CORPORATION
STREET 2: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRADIMED CORP
CENTRAL INDEX KEY: 0001325618
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 731408526
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
BUSINESS PHONE: 4076778022
MAIL ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
4
1
form4.xml
X0407
4
2023-05-05
0001325618
IRADIMED CORP
IRMD
0001613801
Susi Roger E.
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS
FL
32708
true
true
true
President, CEO and Chairman
false
Common Stock
2023-05-05
4
S
0
10000
46.1976
D
502950
I
By Roger E. Susi Revocable Trust
Common Stock
2362500
I
By Matthew Susi 2008 Dynasty Trust
Common Stock
2362500
I
By Phillip Susi 2008 Dynasty Trust
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023.
This transaction was executed in multiple trades at prices ranging from $46.00 to $46.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
/s/ Roger E. Susi
2023-05-05